American International Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-93,415
| Closed | -$475K | – | 315 |
|
2024
Q1 | $475K | Sell |
93,415
-802
| -0.9% | -$4.07K | ﹤0.01% | 1684 |
|
2023
Q4 | $564K | Sell |
94,217
-381
| -0.4% | -$2.28K | ﹤0.01% | 1596 |
|
2023
Q3 | $670K | Buy |
94,598
+3,364
| +4% | +$23.8K | ﹤0.01% | 1444 |
|
2023
Q2 | $642K | Buy |
91,234
+1,712
| +2% | +$12.1K | ﹤0.01% | 1494 |
|
2023
Q1 | $747K | Buy |
89,522
+1,782
| +2% | +$14.9K | ﹤0.01% | 1391 |
|
2022
Q4 | $1.01M | Sell |
87,740
-320
| -0.4% | -$3.67K | 0.01% | 1200 |
|
2022
Q3 | $1.11M | Buy |
88,060
+1,244
| +1% | +$15.7K | 0.01% | 1130 |
|
2022
Q2 | $919K | Sell |
86,816
-2,570
| -3% | -$27.2K | 0.01% | 1248 |
|
2022
Q1 | $1.45M | Sell |
89,386
-6,292
| -7% | -$102K | 0.01% | 1142 |
|
2021
Q4 | $1.33M | Sell |
95,678
-1,637
| -2% | -$22.7K | 0.01% | 1260 |
|
2021
Q3 | $1.4M | Sell |
97,315
-2,312
| -2% | -$33.2K | 0.01% | 1236 |
|
2021
Q2 | $1.58K | Sell |
99,627
-3,325
| -3% | -$53 | 0.01% | 1251 |
|
2021
Q1 | $1.05K | Buy |
102,952
+272
| +0.3% | +$3 | ﹤0.01% | 1431 |
|
2020
Q4 | $765 | Sell |
102,680
-2,946
| -3% | -$22 | ﹤0.01% | 1539 |
|
2020
Q3 | $363K | Buy |
105,626
+11,287
| +12% | +$38.8K | ﹤0.01% | 1768 |
|
2020
Q2 | $450K | Buy |
94,339
+3,300
| +4% | +$15.7K | ﹤0.01% | 1653 |
|
2020
Q1 | $182K | Sell |
91,039
-1,703
| -2% | -$3.41K | ﹤0.01% | 1954 |
|
2019
Q4 | $320K | Buy |
92,742
+23,208
| +33% | +$80.1K | ﹤0.01% | 1943 |
|
2019
Q3 | $199K | Sell |
69,534
-484
| -0.7% | -$1.39K | ﹤0.01% | 2166 |
|
2019
Q2 | $265K | Buy |
70,018
+436
| +0.6% | +$1.65K | ﹤0.01% | 2051 |
|
2019
Q1 | $566K | Sell |
69,582
-2,254
| -3% | -$18.3K | ﹤0.01% | 1632 |
|
2018
Q4 | $580K | Sell |
71,836
-554
| -0.8% | -$4.47K | ﹤0.01% | 1581 |
|
2018
Q3 | $552K | Buy |
72,390
+8,236
| +13% | +$62.8K | ﹤0.01% | 1828 |
|
2018
Q2 | $368K | Buy |
64,154
+1,520
| +2% | +$8.72K | ﹤0.01% | 2019 |
|
2018
Q1 | $299K | Sell |
62,634
-3,368
| -5% | -$16.1K | ﹤0.01% | 2023 |
|
2017
Q4 | $324K | Buy |
66,002
+12,317
| +23% | +$60.5K | ﹤0.01% | 2035 |
|
2017
Q3 | $281K | Buy |
53,685
+4,014
| +8% | +$21K | ﹤0.01% | 2090 |
|
2017
Q2 | $276K | Buy |
49,671
+4,441
| +10% | +$24.7K | ﹤0.01% | 2084 |
|
2017
Q1 | $380K | Buy |
45,230
+2,989
| +7% | +$25.1K | ﹤0.01% | 1785 |
|
2016
Q4 | $267K | Sell |
42,241
-109
| -0.3% | -$689 | ﹤0.01% | 2005 |
|
2016
Q3 | $187K | Buy |
42,350
+64
| +0.2% | +$282 | ﹤0.01% | 2214 |
|
2016
Q2 | $120K | Sell |
42,286
-2,688
| -6% | -$7.63K | ﹤0.01% | 2477 |
|
2016
Q1 | $127K | Buy |
44,974
+500
| +1% | +$1.41K | ﹤0.01% | 3205 |
|
2015
Q4 | $458K | Sell |
44,474
-674
| -1% | -$6.94K | ﹤0.01% | 2101 |
|
2015
Q3 | $515K | Buy |
45,148
+300
| +0.7% | +$3.42K | ﹤0.01% | 1994 |
|
2015
Q2 | $670K | Sell |
44,848
-1,564
| -3% | -$23.4K | ﹤0.01% | 1912 |
|
2015
Q1 | $419K | Sell |
46,412
-1,200
| -3% | -$10.8K | ﹤0.01% | 2305 |
|
2014
Q4 | $579K | Sell |
47,612
-543
| -1% | -$6.6K | ﹤0.01% | 2001 |
|
2014
Q3 | $471K | Buy |
48,155
+1,315
| +3% | +$12.9K | ﹤0.01% | 2198 |
|
2014
Q2 | $597K | Buy |
46,840
+45,840
| +4,584% | +$584K | ﹤0.01% | 2011 |
|
2014
Q1 | $10.6K | Sell |
1,000
-2,500
| -71% | -$26.5K | ﹤0.01% | 4393 |
|
2013
Q4 | $26.6K | Hold |
3,500
| – | – | ﹤0.01% | 4022 |
|
2013
Q3 | $25.5K | Sell |
3,500
-33,866
| -91% | -$247K | ﹤0.01% | 3992 |
|
2013
Q2 | $57.9K | Buy |
+37,366
| New | +$57.9K | ﹤0.01% | 3507 |
|